Mathieu Seyfrid

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

Anne Dirkse, Anna Golebiewska, Thomas Buder et al. · Nature Communications · 2019 · 546 citations · Full text

Medicine, Cell Biology, Oncology +17

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Parvez Vora, Chitra Venugopal, Sabra K. Salim et al. · Cell stem cell · 2020 · 187 citations · Full text

Medicine, Immunology, Oncology +14

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Mathieu Seyfrid, William Maich, Muhammad Vaseem Shaikh et al. · Journal for ImmunoTherapy of Cancer · 2022 · 79 citations · Full text

Medicine, Immunology, Oncology +17

Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells

Parvez Vora, Mathieu Seyfrid, Chitra Venugopal et al. · Journal of Neuro-Oncology · 2019 · 28 citations

Medicine, Cell Biology, Oncology +16

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence

David Bakhshinyan, Ashley Adile, Jeff Liu et al. · Science Advances · 2021 · 25 citations · Full text

Medicine, Cancer Biology, Oncology +17